摘要
在绿茶的主要成分中,表没食子儿茶素-3-没食子酸酯(EGCG)是最有效的抗癌特性。大量的研究提供了EGCG抑制功能的机制,EGCG通过激活/抑制多种信号通路参与了肿瘤细胞周期、发育和凋亡的改变。EGCG在癌症中发挥多重作用的另一个机制是DNA甲基化或甲基转移酶、组蛋白乙酰化或去乙酰化酶以及非编码RNA(micoRNAs)的表观遗传学改变。此外,miRNA转录的反调控表达已被证实可被致癌和肿瘤抑制转录因子直接调控。近年来,EGCG已经鉴定出一些蛋白为miRNA直接相互作用体。然而,EGCG调控miRNA的机制尚未完全被了解。本文综述了EGCG在多种癌症以及致癌和抑癌转录因子中调控表观遗传变化的研究进展。
关键词: 表没食子儿茶素没食子酸盐(EGCG), micoRNA,癌症,表观遗传调节,甲基转移酶,miRNA
图形摘要
[http://dx.doi.org/10.3390/nu10121936] [PMID: 30563268]
[http://dx.doi.org/10.1016/j.nut.2017.06.006] [PMID: 28935149]
[http://dx.doi.org/10.1242/jeb.107110] [PMID: 25568452]
[http://dx.doi.org/10.2174/15680096113139990077] [PMID: 23517596]
[http://dx.doi.org/10.1016/j.bbrc.2012.03.120] [PMID: 22487794]
[http://dx.doi.org/10.2174/092986710791299966] [PMID: 20423306]
[http://dx.doi.org/10.1016/j.lfs.2018.04.041] [PMID: 29705350]
[http://dx.doi.org/10.1039/C7FO01064H] [PMID: 29160895]
[http://dx.doi.org/10.1016/j.biopha.2017.01.161] [PMID: 28292023]
[http://dx.doi.org/10.1093/nar/gkt1011] [PMID: 24165878]
[http://dx.doi.org/10.1080/01635581.2014.894101]
[http://dx.doi.org/10.2174/15680096113139990033] [PMID: 23597195]
[http://dx.doi.org/10.1371/journal.pone.0025982] [PMID: 21998738]
[http://dx.doi.org/10.1016/j.jnutbio.2008.12.003] [PMID: 19269153]
[http://dx.doi.org/10.1016/j.cbi.2015.03.022] [PMID: 25839702]
[http://dx.doi.org/10.3390/molecules24162899] [PMID: 31404982]
[http://dx.doi.org/10.3390/cancers11010023] [PMID: 30591655]
[http://dx.doi.org/10.3390/ijms19123970] [PMID: 30544666]
[http://dx.doi.org/10.1159/000480636] [PMID: 29040973]
[http://dx.doi.org/10.1080/01635581.2017.1359322] [PMID: 28872903]
[http://dx.doi.org/10.1038/s41598-017-09764-3] [PMID: 28839265]
[http://dx.doi.org/10.1002/mc.22121] [PMID: 24481780]
[http://dx.doi.org/10.1007/s10549-015-3295-5] [PMID: 25663548]
[http://dx.doi.org/10.1021/tx200378c] [PMID: 21992498]
[http://dx.doi.org/10.1158/1940-6207.CAPR-11-0009] [PMID: 21411498]
[http://dx.doi.org/10.1186/1476-4598-9-274] [PMID: 20946668]
[http://dx.doi.org/10.1002/jcp.26900] [PMID: 30078217]
[PMID: 25682960]
[PMID: 30783443]
[PMID: 19528461]
[http://dx.doi.org/10.1093/carcin/bgr218] [PMID: 21965273]
[http://dx.doi.org/10.2174/1566524018666171219101937] [PMID: 29256350]
[http://dx.doi.org/10.1002/mc.23003] [PMID: 30854739]
[http://dx.doi.org/10.1002/mc.22901] [PMID: 30182373]
[http://dx.doi.org/10.1002/jcb.27117] [PMID: 30058740]
[PMID: 29256350]
[http://dx.doi.org/10.1096/fj.10-167924] [PMID: 21177307]
[http://dx.doi.org/10.1016/j.cellsig.2015.03.021] [PMID: 25843776]
[http://dx.doi.org/10.1093/carcin/bgq285] [PMID: 21209038]
[http://dx.doi.org/10.1093/carcin/bgp314] [PMID: 20015867]
[http://dx.doi.org/10.1007/s13277-015-4187-3] [PMID: 26499783]
[http://dx.doi.org/10.1016/j.fct.2018.10.052] [PMID: 30408543]
[http://dx.doi.org/10.1038/srep19225] [PMID: 26754091]
[http://dx.doi.org/10.1016/j.biopha.2017.01.078] [PMID: 28167449]
[http://dx.doi.org/10.18632/oncotarget.9204] [PMID: 27167203]
[http://dx.doi.org/10.1016/j.yexcr.2014.01.024] [PMID: 24518414]
[http://dx.doi.org/10.3389/fonc.2012.00057] [PMID: 22675672]
[http://dx.doi.org/10.1016/j.jnutbio.2013.04.006] [PMID: 23954321]
[http://dx.doi.org/10.1111/1440-1681.12854] [PMID: 28925507]
[http://dx.doi.org/10.1124/mol.104.008367] [PMID: 16037419]
[PMID: 20596647]
[http://dx.doi.org/10.3892/ijo.24.3.703] [PMID: 14767556]
[http://dx.doi.org/10.1038/ncb985] [PMID: 12717449]
[http://dx.doi.org/10.1186/s12943-018-0856-3] [PMID: 30045773]
[http://dx.doi.org/10.1158/0008-5472.CAN-06-4327] [PMID: 17575143]
[PMID: 25550533]
[http://dx.doi.org/10.1155/2013/821082] [PMID: 23476753]